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CASE REPORT
Benign orbital angiomatous tumors 
with intracranial extension
Konrad R Koch1, Mario Matthaei1, Stefan J Grau2, Tobias Blau3, Edwin Bölke4*, Ole Schlichting1, Claus Cursiefen1 
and Ludwig M Heindl1
Abstract 
Orbital neoplasms with associated bone erosions and intracranial extension are generally considered suspicious for 
malignancies. Here, we describe the clinical and radiological findings, as well as the surgical management of two 
extraordinary cases, in which such bony perforations with subsequent intracranial tumor growth resulted from benign 
angiomatous orbital neoplasms. Two female patients, 69 years old (case 1) and 51 years old (case 2), had both devel-
oped visual symptoms (visual field restrictions and/or visual acuity loss) over several months. Computed tomography 
revealed an orbital tumor of the anterosuperior orbit with painless swelling of the medial upper eyelid of the right eye 
in case 1, and a posterior intraconal tumor close to the orbital apex of the left eye in case 2, respectively. In both cases, 
the tumor was associated with a perforation of the orbital roof connecting the orbit with the anterior cranial fossa. An 
interdisciplinary ophthalmologic and neurosurgical approach allowed for complete tumor removal, in both patients 
with no signs for local recurrence during the subsequent follow-up of 15 and 18 months, respectively, as well as for a 
satisfactory visual rehabilitation.
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Background
Orbital tumors although relatively rare with an esti-
mated incidence of around 3 cases in one million people 
comprise a variety of benign and malignant neoplastic 
entities [1, 2]. Given that the orbit is encircled laterally 
and posteriorly by bony walls, these tumors as space-
consuming lesions become most often clinically evident 
by an axial protrusion of the ipsilateral eye (proptosis) 
[3–5]. Depending on the primary tumor localization 
within or outside the extraocular muscle cone, propto-
sis can be associated with a significant downward or lat-
eral displacement of the eye globe. With growing tumor 
diameters compression of the optic nerve can result in 
irreversible functional deterioration including visual 
acuity loss and visual field defects. Depending on the 
degree of proptosis reduced ocular surface lubrication 
and incomplete lid closure may cause additional corneal 
disease. Impaired motility of the ipsilateral extraocular 
muscles with subsequent diplopia may equally appear.
In order to choose an adequate diagnostic as well 
as therapeutic approach, not only tumor dimensions 
and localization have to be considered but also and as 
importantly the benign versus malignant character of 
the lesion. While benign tumors may be observed and 
assessed conservatively as long as the (bin)ocular func-
tion remains unaffected [6], malignant entities require an 
immediate and more radical treatment, which apart from 
surgical tumor removal by means of an orbitotomy may 
enclose adjuvant chemo- or radiotherapeutical measures.
In turn, incisional and excisional orbital surgery is 
demanding, often requiring a multidisciplinary approach 
of orbitoplastic, neurosurgical, and maxillofacial surgical 
specialists, and is associated by itself with a significant 
risk for the ocular function [7, 8]. The surgical indication 
should therefore be weighed carefully always based on 
clinical, echographical, and radiological findings.
Commonly, tumor derived perforations of the bony 
orbit are among those radiological features raising suspi-
cion for a malignancy, thus also impacting therapeutical 
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decisions. However, very rarely bony erosions and intrac-
ranial tumor extension may derive from benign orbital 
tumors as well, which we demonstrate with this series 
of two patients, who presented between 09/2013 and 
03/2014 to our oculoplastic and ophthalmo-oncological 
service at the Department of Ophthalmology, University 
of Cologne, Cologne, Germany, with anterior (case 1) and 




A 69-year-old female patient was referred to our hospi-
tal in 09/2013 with a tumor of the anterosuperior orbit 
accompanied by a pea-sized livid painless swelling of the 
medial upper eyelid of the right eye. Based on the his-
tory and portrait photographs, a significant increase in 
tumor size could be assessed over an 18-month-period. 
According to the anterior localization in the orbital 
entrance Hertel exophthalmometry revealed no protru-
sion of the ipsilateral eye globe. Functionally, the tumor 
did not affect best-corrected visual acuity (BCVA, 20/20 
right eye) or ocular motility. However, swelling of the 
upper eyelid (Fig. 1a) resulted in a restriction of the supe-
rior visual field. Radiologically, computed tomography 
(CT) images revealed a well-circumscribed tumor with 
a maximum diameter of 17.0 mm and large-scale loss of 
the anterior orbital roof connecting the orbit with the 
anterior cranial fossa (Fig. 1b). In T1-weighted magnetic 
resonance imaging (MRT) the tumor signal was isoin-
tense compared to the extraocular muscles before con-
trast application and showed an inhomogeneous contrast 
medium uptake (Fig.  1c). Due to documented tumor 
growth, to the perimetric symptoms, and to the large-
scale bone erosion of the orbital roof connecting the 
orbit with the anterior cranial fossa, the patient under-
went excisional surgery in 01/2014. Since the tumor 
was pediculated through the bony perforation widely 
stretching into the frontobasal dura, complete excision 
by means of an anterior transcutaneous orbitotomy alone 
was not possible, but was achieved with an additional 
small orbital craniotomy with focal dural resection and 
cauterization. Histopathologically, the tumor was com-
posed of partly small capillary vessels and partly larger 
vascular malformations, areas of fresh hemorrhages and 
hemosiderin deposits, embedded in mature adipose as 
well as fibrotic connective tissue. Immunohistochemical 
staining was positive for blood endothelial markers CD31 
and CD34, while being negative for lymphatic endothe-
lial marker LYVE-1, and for melanocytic marker S-100. 
Staining of proliferation marker Ki-67 revealed only sin-
gular immune-activated leucocytes. Accordingly, the 
orbital tumor was diagnosed as capillary hemangioma 
associated with an arteriovenous malformation. After 
Fig. 1 Anterior orbital mass in the right eye of a 69-year-old patient (case 1). a Livid swelling of the medial upper lid causing visual field restriction. 
b Computed tomography revealing a large-scale defect of the orbital roof (white arrows). c T1-weighted contrast-enhanced magnetic resonance 
tomography showing a round lesion with irregular hyperintensity (asterisk). d Histopathological section showing a arteriosus malformation as well 
as components of a capillary hemangioma (arrows, H&E staining, original magnification ×200).
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resorption of the postsurgical lid edema, no residual 
visual field defects were detectable (OD). During the sub-
sequent 18-months-follow-up, repeated clinical and ech-
ographic monitoring and MRT imaging revealed no signs 
for an orbital or frontobasal tumor recurrence.
Case 2
A 51-year-old female patient presented to our clinic in 
03/2014 reporting a progressive visual impairment in her 
left eye over 6 months. BCVA was reduced to 20/40 and 
30° perimetry showed a concentric visual field restric-
tion. Hertel exophthalmometry showed a slight 2  mm 
proptosis of the left eye  (Fig.  2a). Ocular motility was 
unaffected. CT imaging revealed a round, well-circum-
scribed posterior intraconal tumor close to the orbital 
apex, with a maximum diameter of 16.3  mm surround-
ing the optic nerve with an adjacent perforation of the 
superior orbital bony wall towards the anterior cranial 
fossa (Fig. 2b). In MRT scans, similar to case 1 the tumor 
was isointense to the extraocular muscles (hypointense to 
the orbital fat) before contrast enhancement, while show-
ing irregular hyperintensity following contrast medium 
uptake  (Fig.  2c). In view of the visual symptoms attrib-
utable to compressive optic neuropathy surgical inter-
vention was mandatory. Due to the tumor localization 
in the orbital apex, a transcranial orbitotomy approach 
with pterional craniotomy was chosen, which allowed 
for complete excision of the intraconal tumor, which did 
not adhere to the optic nerve. Histopathological evalu-
ation showed a hemangioma of a mixed capillary and 
cavernous type  (Fig.  2d), thereby confirming the mac-
roscopic assumption during surgery. In the postsurgical 
course, proptosis of the left eye resolved completely. Vis-
ual field defects were slightly regressing and visual acuity 
increased to 20/30. During the 15-month follow-up, no 
sign of tumor recurrence was clinically and radiologically 
detectable.
Vascular tumors, particularly cavernous hemangiomas 
in adults and capillary hemangiomas in infants, belong to 
the most frequent primary benign orbital neoplasms [9]. 
As the present cases typically demonstrate, these tumors 
can be located in the anterior (orbital entrance) or in the 
posterior orbit (orbital cone and apex), in the intraconal 
and less often in the extraconal space [9]. Also with regard 
to their well-demarcated and rather spherical shape, the 
tumors of this series can be considered representative 
[10]. However, vascular as well as other benign tumors are 
by definition incapable of invading neighboring tissues, 
thus primarily raising the suspicion for malignancy when 
bony erosions adjacent to an orbital neoplasm become 
radiologically apparent. Indeed, perforations of the bony 
orbital roof resulting in a patent connection between orbit 
and cranial cavity, which are caused by the angiomatous 
benign tumors described here, are highly exceptional. An 
Fig. 2 Posterior intraconal tumor in the left orbit of a 51-year-old female patient (case 2). a Forward shift of the upper lid skin crease as sign of 
mild proptosis (arrow). b Bone perforation connecting the orbit with the anterior cranial fossa (arrow, computed tomography). c Irregular contrast 
enhancement of the well-circumscribed round tumor after on T1-weighted magnetic resonance tomography (asterisk) impairing visual acuity. d 
Histopathologic evaluation showing large cavernous vessels (arrows), confirming the diagnosis of a hemangioma (Elastica van Gieson staining, 
original magnification ×50).
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extensive literature search revealed only three previously 
published single cases of bone erosions caused by primary 
orbital hemangiomas [11–13], among which only one 
showed a perforation of the orbital roof [12]. The present 
cases demonstrate that such orbital roof perforations can 
originate from benign angiomatous tumors of both, the 
orbital entrance and the orbital apex. In the single case 
described by Yan et al., the orbital roof defect was associ-
ated with sound adhesion of the hemangioma to the sur-
rounding tissues thus aggravating the operation [12]. This 
observation corresponds to the surgical findings in our 
case 1, where strong adhesion with the frontobasal dura 
required a focal durectomy. Such adhesion complicates 
and prolongs surgery significantly apart from the poten-
tial need to reconstruct bony defects using implants such 
as resorbable polydioxanon foils.
Among the mechanisms, which might contribute to 
bone destruction adjacent to benign orbital tumors, a 
pressure-induced atrophy might as well come into ques-
tion as a pro-osteoclastic growth factor milieu derived 
from tumor surrounding inflammatory cells [14].
Conclusions
Bone erosions related to tumoral orbital lesions, even 
though remaining suspect for malignant neoplastic enti-
ties may be the result of angiomatous benign lesions. Our 
cases and the few previously published ones underline 
that the assumed diagnosis, the differentiation between 
benign and malignant entities, and the subsequent 
urgency for surgical interventions should be based on as 
many clinical and radiological criteria as available, rather 
than on isolated findings that might lack sufficient sensi-
tivity and specificity [15].
If surgery of orbital neoplasms with bone perforations 
and intracranial extension is intended, a more compli-
cated and prolonged surgical course should be antici-
pated, since stronger tissue adhesions might be found. 
Since little invasive extracranial approaches usually per-
formed by orbital and ophthalmic plastic surgeons are 
unsuitable to make such tumors accessible and resectable 
as a whole, transcranial interdisciplinary approaches are 
mandatory, allowing for complete tumor removal as well 
as for rehabilitation of visual functions.
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